Rock Springs Capital Management LP Celldex Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $1.67 Billion
- Q1 2025
A detailed history of Rock Springs Capital Management LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 812,653 shares of CLDX stock, worth $17.8 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
812,653
Previous 1,222,182
33.51%
Holding current value
$17.8 Million
Previous $30.9 Million
52.24%
% of portfolio
0.88%
Previous 1.23%
Shares
12 transactions
Others Institutions Holding CLDX
# of Institutions
190Shares Held
69.3MCall Options Held
220KPut Options Held
310K-
Wellington Management Group LLP Boston, MA8.35MShares$183 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.5MShares$143 Million9.94% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$85.6 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$82.4 Million1.45% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.03B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...